Merit Medical Systems Inc (MMSI)
Health Services • Health Care
July 02, 2026 Merit Medical Systems to Release Second Quarter 2026 Results Merit Medical Systems will release its Q2 2026 financial results on July 30, followed by an investor conference call. This event will provide insights into the company's performance and future outlook.
May 19, 2026 Merit Medical Systems Welcomes Scott R. Ward to Board of Directors Merit Medical Systems has elected Scott R. Ward to its Board of Directors, bringing over 40 years of healthcare experience. His leadership is expected to drive innovation and growth for the company.
May 08, 2026 Merit Medical Systems Inc. to Showcase Innovations at Bank of America Healthcare Conference Merit Medical Systems will showcase its innovations at the Bank of America Healthcare Conference in May 2026, featuring a fireside chat aimed at engaging investors. The session will provide insights into the company's strategic initiatives and product developments.
April 30, 2026 Merit Medical Systems Inc Reports Strong First Quarter 2026 Results Merit Medical Systems Inc. reported a 7% revenue increase in Q1 2026, driven by organic growth and enhanced profitability. The company has made strategic divestments and acquisitions to strengthen its market position and streamline operations.
April 30, 2026 Merit Medical Systems Inc. Reports Strong Q1 2026 Financial Results Merit Medical Systems Inc. reported a 7% increase in sales for Q1 2026, driven by strong performance in both foundational and therapeutic products. The company's net income rose significantly, supported by strategic acquisitions and a focus on innovation, positioning it well for future growth.
April 02, 2026 Merit Medical Systems to Release First Quarter 2026 Financial Results Merit Medical Systems is set to announce its Q1 2026 financial results on April 30. The announcement will be followed by an investor conference call to discuss performance and strategies. The company continues to be a leader in healthcare technology.
April 01, 2026 Merit Medical Systems Expands Therapeutic Oncology Portfolio with Acquisition of View Point Medical Merit Medical Systems has acquired View Point Medical for $140 million to enhance its therapeutic oncology offerings. The integration of View Point's innovative imaging technology aims to improve breast cancer diagnostics and localization procedures, benefiting patient outcomes.
March 16, 2026 Merit Medical Systems Inc. Unveils Revolutionary Esophageal Stent Merit Medical Systems Inc. has launched the Resilience Through-the-Scope Esophageal Stent, a groundbreaking solution for esophageal conditions. This innovative stent improves patient outcomes and reduces the need for invasive surgeries, addressing the rising global prevalence of esophageal diseases.
February 24, 2026 Merit Medical Systems Inc. Reports Strong Q4 and Full Year 2025 Results Merit Medical Systems Inc. announced impressive Q4 and full-year results for 2025, with notable revenue and EPS growth. The company projects continued growth for 2026, reinforcing its strong market position.
February 24, 2026 Merit Medical Systems Inc. Reports Strong Financial Performance in 2025 In 2025, Merit Medical Systems Inc. reported $1.516 billion in sales, an 11.8% increase from the previous year. Key drivers included growth in cardiovascular and endoscopy segments, alongside strategic acquisitions to enhance product offerings.
January 08, 2026 Merit Medical Systems Inc. Announces Leadership Transition and Strong Revenue Projections Merit Medical Systems has appointed F. Ann Millner as Chair of the Board following the resignation of Fred P. Lampropoulos. The company also reported strong preliminary revenue results for Q4 2025, with a projected increase of 10-11% year-over-year, positioning itself for continued growth in the healthcare technology sector.
December 23, 2025 Merit Medical Systems to Showcase Innovations at J.P. Morgan Healthcare Conference Merit Medical Systems will participate in the 44th Annual J.P. Morgan Healthcare Conference from January 12-15, 2026. CEO Martha G. Aronson will present on January 13, highlighting the company’s innovations and strategic initiatives, with resources available for investors.
November 13, 2025 Merit Medical Systems Provides Strategic Update on WRAPSODY® Endoprosthesis Merit Medical Systems announced a strategic update regarding its WRAPSODY® Endoprosthesis, opting to withdraw a payment application in favor of full commercialization. CEO Martha G. Aronson views this as an opportunity to enhance patient access and leverage strong clinical data, aiming for significant market growth in dialysis access maintenance.
November 05, 2025 Merit Medical Systems Reports Promising 24-Month Results from WAVE Trial Merit Medical Systems has reported significant 24-month findings from its WAVE trial, showcasing the efficacy of the WRAPSODY CIE device over standard treatments for hemodialysis patients. The device demonstrated superior patency rates, addressing critical challenges in vascular access. Expert insights highlight the device's potential to improve patient outcomes significantly.
November 03, 2025 Merit Medical Systems Inc. Announces Promising 24-Month Efficacy Results from WAVE Trial Merit Medical Systems announced promising 24-month efficacy results from the WAVE trial, showcasing the WRAPSODY CIE's effectiveness in restoring vascular access for hemodialysis patients. The trial demonstrated significant outcomes, positioning the device as a potential game-changer in managing AVG complications.
October 30, 2025 Merit Medical Systems Inc. Reports Strong Q3 2025 Results and Updates Full-Year Guidance Merit Medical Systems Inc. announced a strong Q3 2025 with a 13% revenue increase to $384.2 million. The company demonstrated operational efficiency with improved margins and a robust cash flow of $141.6 million, prompting an optimistic update on its full-year guidance.
October 30, 2025 Merit Medical Systems Inc. Reports Strong Q3 2025 Earnings Amid Strategic Changes Merit Medical Systems Inc. reported strong Q3 2025 earnings with total sales rising to $384.2 million, driven by growth in cardiovascular and endoscopy segments. Despite increased operating expenses, the company's commitment to innovation and market expansion positions it for future success.
October 15, 2025 Merit Medical Systems to Acquire C2 CryoBalloon Technology from PENTAX Medical Merit Medical Systems has signed a definitive agreement to acquire the C2 CryoBalloon™ technology from PENTAX Medical, aimed at improving treatment for gastrointestinal disorders. This strategic move underscores Merit's commitment to minimally invasive solutions and positions the company for future growth in the gastroenterology market.
October 03, 2025 Merit Medical Systems Set to Announce Third Quarter 2025 Results Merit Medical Systems is set to release its third quarter financial results on October 30, 2025, followed by an investor conference call. This announcement is crucial for stakeholders to assess the company's performance in the evolving healthcare landscape.
October 01, 2025 Merit Medical Achieves Remarkable SCOUT Milestone: 750,000 Patients Treated with Innovative Wire-Free Technology Merit Medical has reached a significant milestone, treating 750,000 patients with its SCOUT Radar Localization technology for breast cancer. This innovative method enhances surgical precision and patient outcomes, highlighting the importance of advanced treatment options during Breast Cancer Awareness Month.
July 30, 2025 Merit Medical Systems Inc. Reports Solid Growth in Q2 2025 Merit Medical Systems Inc. reported a 13.2% sales increase in Q2 2025 but saw a decline in net income due to rising operating expenses. The company's strategic acquisitions and strong performance in cardiovascular and endoscopy segments highlight its growth potential despite current challenges.
March 27, 2025 Merit Medical Systems Inc. Sees Significant Endorsement for TIF 2.0 Procedures Merit Medical Systems has received significant endorsement as ASGE updates its guidelines to include TIF 2.0 and cTIF for GERD treatment. These minimally invasive procedures show high success rates and improve patient quality of life, marking a pivotal advancement in gastroesophageal reflux disease management.
March 25, 2025 Merit Medical Systems Inc. Announces Promising 12-Month Results for WRAPSODY® CIE Merit Medical Systems announced promising 12-month results for its WRAPSODY® CIE, highlighting superior efficacy over standard treatments in the WAVE trial. The device significantly improves vascular access for hemodialysis patients, marking a crucial advancement in patient care.
March 18, 2025 Merit Medical Celebrates 35-Year Nasdaq Partnership with Opening Bell Ceremony On March 19, 2025, Merit Medical Systems celebrated 35 years on Nasdaq with an opening bell ceremony led by CEO Fred Lampropoulos. This milestone underscores the company's commitment to innovation in healthcare technology and the importance of strategic partnerships.
March 10, 2025 SWOT Analysis of Merit Medical Systems Inc. in 2025 This SWOT analysis of Merit Medical Systems Inc. for 2025 outlines its key strengths, such as strong market leadership and innovation, as well as weaknesses like regulatory vulnerabilities. It also identifies opportunities for expansion in international markets and the challenges posed by competitive pressures and compliance issues.
March 10, 2025 Merit Medical Systems Inc. Launches Groundbreaking PREEMIE Study for Premature Infants Merit Medical Systems has initiated the PREEMIE study to assess the Bloom Micro Occluder System for treating patent ductus arteriosus (PDA) in premature infants. This innovative approach promises to enhance safety and efficacy in treating this vulnerable population, with the first patient now enrolled in the trial.
February 25, 2025 Merit Medical Systems Inc. 2024 Annual Report: Strong Growth and Strategic Acquisitions Merit Medical Systems Inc. reported a 7.9% increase in revenue for 2024, reaching $1.357 billion. The company made significant acquisitions and launched innovative products, highlighting its growth in the cardiovascular and endoscopy segments.
February 25, 2025 Merit Medical Systems Inc. Reports Strong Q4 2024 Results and Provides 2025 Guidance Merit Medical Systems Inc. reported strong financial results for Q4 2024, with a revenue increase of 9.4%. The company also provided an optimistic guidance for 2025, projecting revenue growth and improved profitability metrics, supported by strategic acquisitions and innovations.
October 30, 2024 Merit Medical Systems Inc. Reports Strong Q3 2024 Financial Results Merit Medical Systems Inc. has reported robust Q3 2024 financial results, with a revenue increase of 7.8% to $339.8 million. Notable growth in cardiovascular and endoscopy segments highlights the company's strategic acquisitions and commitment to innovation in the healthcare sector.
August 01, 2024 Merit Medical Systems Inc. Reports Strong Q2 2024 Financial Results Merit Medical Systems Inc. reported strong financial results for Q2 2024, with sales reaching $338 million, a 5.6% increase year-over-year. The company demonstrated robust performance in both cardiovascular and endoscopy segments, along with improved operating income and a solid balance sheet, positioning it for future growth.
April 30, 2024 Merit Medical Systems Inc. Reports Strong Q1 2024 Results Merit Medical Systems Inc. reported an impressive 8.7% increase in sales for Q1 2024, reaching $323.5 million. The company showed robust growth in its cardiovascular and endoscopy segments, alongside a significant rise in net income. With a strong financial position and innovative product launches, Merit Medical is well-positioned for continued success.